2018
Survival Outcomes and Prognostic Factors for Gastric Cancer in the Adjuvant Setting: An Analysis of the National Cancer Database
Nguy S, Wu P, Lee A, Tam M, Schreiber D, Du K. Survival Outcomes and Prognostic Factors for Gastric Cancer in the Adjuvant Setting: An Analysis of the National Cancer Database. International Journal Of Radiation Oncology • Biology • Physics 2018, 102: e49. DOI: 10.1016/j.ijrobp.2018.07.462.Peer-Reviewed Original Research
2017
Biomarkers that Predict Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer
Oh P, Du K. Biomarkers that Predict Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer. Current Colorectal Cancer Reports 2017, 13: 276-283. DOI: 10.1007/s11888-017-0376-3.Peer-Reviewed Original ResearchAdvanced rectal cancerRectal cancerNeoadjuvant chemoradiationComplete responsePathologic complete responseStandard of careBowel functionNeoadjuvant therapyOverall survivalTumor responsePotential complicationsChemoradiationBiologic factorsTreatment correlatesCancerSurgeryRecent reportsCurrent literatureBiomarkersResponseComplicationsPatientsTherapyCare
2015
Radiation Therapy Induces an Immunosuppressive Immune Infiltrate in a Murine Model of Invasive Pancreatic Cancer
Nguy S, Tomkoetter L, Alothman S, Alqunaibit D, Miller G, Du K. Radiation Therapy Induces an Immunosuppressive Immune Infiltrate in a Murine Model of Invasive Pancreatic Cancer. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: s95-s96. DOI: 10.1016/j.ijrobp.2015.07.229.Peer-Reviewed Original Research
2014
Significantly Worse Colostomy-Free Survival in Human Immunodeficiency Virus–Positive Patients After Definitive Chemoradiation for Anal Cancer
Grew D, Bitterman D, Leichman C, Leichman L, Du K. Significantly Worse Colostomy-Free Survival in Human Immunodeficiency Virus–Positive Patients After Definitive Chemoradiation for Anal Cancer. International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s398-s399. DOI: 10.1016/j.ijrobp.2014.05.1273.Peer-Reviewed Original Research
2013
Chemoradiation Therapy Versus Chemotherapy Alone for Gastric Cancer After R0 Surgical Resection: A Meta-Analysis of Randomized Trials
Min C, Bangalore S, Jhawar S, Guo Y, Nicholson J, Formenti S, Leichman L, Du K. Chemoradiation Therapy Versus Chemotherapy Alone for Gastric Cancer After R0 Surgical Resection: A Meta-Analysis of Randomized Trials. International Journal Of Radiation Oncology • Biology • Physics 2013, 87: s86. DOI: 10.1016/j.ijrobp.2013.06.223.Peer-Reviewed Original Research
2006
Preliminary results of interstitial motexafin lutetium‐mediated PDT for prostate cancer
Du KL, Mick R, Busch TM, Zhu TC, Finlay JC, Yu G, Yodh AG, Malkowicz SB, Smith D, Whittington R, Stripp D, Hahn SM. Preliminary results of interstitial motexafin lutetium‐mediated PDT for prostate cancer. Lasers In Surgery And Medicine 2006, 38: 427-434. PMID: 16788929, DOI: 10.1002/lsm.20341.Peer-Reviewed Original ResearchConceptsInterstitial photodynamic therapyProstate adenocarcinomaProstate cancerPhotodynamic therapyRecurrent prostate adenocarcinomaSolid organ diseaseSubsequent tissue necrosisOrgan diseaseDrug levelsPreclinical studiesClinical experienceSTUDY DESIGN/MATERIALSTissue necrosisDose distributionDESIGN/MATERIALSPhase IAdenocarcinomaHuman subjectsProstateCancerTreatmentUniversity of PennsylvaniaDose variationComprehensive treatmentPatients